BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 18678928)

  • 1. Density heterogeneities and the influence of multiple Coulomb and nuclear scatterings on the Bragg peak distal edge of proton therapy beams.
    Sawakuchi GO; Titt U; Mirkovic D; Mohan R
    Phys Med Biol; 2008 Sep; 53(17):4605-19. PubMed ID: 18678928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A particle track-repeating algorithm for proton beam dose calculation.
    Li JS; Shahine B; Fourkal E; Ma CM
    Phys Med Biol; 2005 Mar; 50(5):1001-10. PubMed ID: 15798272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monte Carlo simulations of a nozzle for the treatment of ocular tumours with high-energy proton beams.
    Newhauser W; Koch N; Hummel S; Ziegler M; Titt U
    Phys Med Biol; 2005 Nov; 50(22):5229-49. PubMed ID: 16264250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual scattering foil design for poly-energetic electron beams.
    Kainz KK; Antolak JA; Almond PR; Bloch CD; Hogstrom KR
    Phys Med Biol; 2005 Mar; 50(5):755-67. PubMed ID: 15798252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pencil beam algorithm for intensity modulated proton therapy derived from Monte Carlo simulations.
    Soukup M; Fippel M; Alber M
    Phys Med Biol; 2005 Nov; 50(21):5089-104. PubMed ID: 16237243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assigning nonelastic nuclear interaction cross sections to Hounsfield units for Monte Carlo treatment planning of proton beams.
    Palmans H; Verhaegen F
    Phys Med Biol; 2005 Mar; 50(5):991-1000. PubMed ID: 15798271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calculations of neutron dose equivalent exposures from range-modulated proton therapy beams.
    Polf JC; Newhauser WD
    Phys Med Biol; 2005 Aug; 50(16):3859-73. PubMed ID: 16077232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monte Carlo investigation of collimator scatter of proton-therapy beams produced using the passive scattering method.
    Titt U; Zheng Y; Vassiliev ON; Newhauser WD
    Phys Med Biol; 2008 Jan; 53(2):487-504. PubMed ID: 18185001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A beam source model for scanned proton beams.
    Kimstrand P; Traneus E; Ahnesjö A; Grusell E; Glimelius B; Tilly N
    Phys Med Biol; 2007 Jun; 52(11):3151-68. PubMed ID: 17505095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Monte Carlo SRNA-VOX code for 3D proton dose distribution in voxelized geometry using CT data.
    Ilić RD; Spasić-Jokić V; Belicev P; Dragović M
    Phys Med Biol; 2005 Mar; 50(5):1011-7. PubMed ID: 15798273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shielding design for a laser-accelerated proton therapy system.
    Fan J; Luo W; Fourkal E; Lin T; Li J; Veltchev I; Ma CM
    Phys Med Biol; 2007 Jul; 52(13):3913-30. PubMed ID: 17664585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET monitoring of cancer therapy with 3He and 12C beams: a study with the GEANT4 toolkit.
    Pshenichnov I; Larionov A; Mishustin I; Greiner W
    Phys Med Biol; 2007 Dec; 52(24):7295-312. PubMed ID: 18065840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel patch-field design using an optimized grid filter for passively scattered proton beams.
    Li Y; Zhang X; Dong L; Mohan R
    Phys Med Biol; 2007 Jun; 52(12):N265-75. PubMed ID: 17664545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monte Carlo feasibility study of orthogonal bremsstrahlung beams for improved radiation therapy imaging.
    Jabbari K; Sarfehnia A; Podgorsak EB; Seuntjens JP
    Phys Med Biol; 2007 Feb; 52(4):1171-84. PubMed ID: 17264378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of photon beam flatness for radiation therapy.
    Olofsson J; Nyholm T; Ahnesjö A; Karlsson M
    Phys Med Biol; 2007 Mar; 52(6):1735-46. PubMed ID: 17327659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implementation of enhanced dynamic wedges into the Pinnacle treatment planning system: Monte Carlo validation and patient-specific QA.
    Ahmad M; Deng J; Lund MW; Chen Z; Kimmett J; Moran MS; Nath R
    Phys Med Biol; 2009 Jan; 54(2):447-65. PubMed ID: 19098353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbeam radiation therapy: tissue dose penetration and BANG-gel dosimetry of thick-beams' array interlacing.
    Dilmanian FA; Romanelli P; Zhong Z; Wang R; Wagshul ME; Kalef-Ezra J; Maryanski MJ; Rosen EM; Anschel DJ
    Eur J Radiol; 2008 Dec; 68(3 Suppl):S129-36. PubMed ID: 18606516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calculation of the positron distribution from 15O nuclei formed in nuclear reactions in human tissue during proton therapy.
    Tuckwell W; Bezak E
    Phys Med Biol; 2007 May; 52(9):2483-98. PubMed ID: 17440247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
    Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
    Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.